Biocytogen Pharmaceuticals (Beijing) Co., Ltd.- B - H Shares
Research Biocytogen Pharmaceuticals (Beijing) Co., Ltd.- B - H Shares: 14 recent indexed disclosure records, public filings, ownership and institutional activity on RealitySeller. Latest indexed activity: 2026-09-22.
company · HK
Research summary
RealitySeller currently indexes 14 recent disclosure records for this company. The latest indexed categories are HKEX-DI-undefined (14). Institutional-holder data is shown separately when an issuer-to-holding link is available.
These figures describe RealitySeller's indexed public-source dataset, not a complete record of every disclosure worldwide. Always verify material information against the original regulator, exchange or issuer filing.
This profile brings together publicly indexed disclosure records associated with Biocytogen Pharmaceuticals (Beijing) Co., Ltd.- B - H Shares, including filings and ownership-related activity where the underlying source data is available. Dates and reported values reflect the indexed filing records and should be checked against the original source for material decisions.
Disclosure categories
Institutional holders
Latest indexed SEC 13F holder snapshot where issuer linkage is available.
- No institutional holder snapshot is indexed for this company yet.
Latest disclosures
- HKEX-DI-undefined · 2026-09-22 · 招銀國際金融有限公司 disclosed an HKEX interest in Biocytogen Pharmaceuticals (Beijing) Co., Ltd.- B - H Shares (02315); class: H Shares; reason: 1201 (L); transaction: 1,016,500(L) Source ↗
- HKEX-DI-undefined · 2026-09-22 · 招銀國際金融控股有限公司 disclosed an HKEX interest in Biocytogen Pharmaceuticals (Beijing) Co., Ltd.- B - H Shares (02315); class: H Shares; reason: 1201 (L); transaction: 1,016,500(L) Source ↗
- HKEX-DI-undefined · 2026-09-22 · 招商銀行股份有限公司 disclosed an HKEX interest in Biocytogen Pharmaceuticals (Beijing) Co., Ltd.- B - H Shares (02315); class: H Shares; reason: 1201 (L); transaction: 1,016,500(L) Source ↗
- HKEX-DI-undefined · 2026-09-22 · CMBI Private Equity Series SPC disclosed an HKEX interest in Biocytogen Pharmaceuticals (Beijing) Co., Ltd.- B - H Shares (02315); class: H Shares; reason: 1201 (L); transaction: 1,016,500(L) Source ↗
- HKEX-DI-undefined · 2026-09-22 · CMB International Private Investment Limited disclosed an HKEX interest in Biocytogen Pharmaceuticals (Beijing) Co., Ltd.- B - H Shares (02315); class: H Shares; reason: 1201 (L); transaction: 1,016,500(L) Source ↗
- HKEX-DI-undefined · 2026-09-22 · CMB International Investment Management Limited disclosed an HKEX interest in Biocytogen Pharmaceuticals (Beijing) Co., Ltd.- B - H Shares (02315); class: H Shares; reason: 1201 (L); transaction: 1,016,500(L) Source ↗
- HKEX-DI-undefined · 2026-09-22 · Astral Eminent Limited disclosed an HKEX interest in Biocytogen Pharmaceuticals (Beijing) Co., Ltd.- B - H Shares (02315); class: H Shares; reason: 1201 (L); transaction: 1,016,500(L) Source ↗
- HKEX-DI-undefined · 2026-09-17 · 招銀國際金融有限公司 disclosed an HKEX interest in Biocytogen Pharmaceuticals (Beijing) Co., Ltd.- B - H Shares (02315); class: H Shares; reason: 1201 (L); transaction: 999,500(L) Source ↗
- HKEX-DI-undefined · 2026-09-17 · 招銀國際金融控股有限公司 disclosed an HKEX interest in Biocytogen Pharmaceuticals (Beijing) Co., Ltd.- B - H Shares (02315); class: H Shares; reason: 1201 (L); transaction: 999,500(L) Source ↗
- HKEX-DI-undefined · 2026-09-17 · 招商銀行股份有限公司 disclosed an HKEX interest in Biocytogen Pharmaceuticals (Beijing) Co., Ltd.- B - H Shares (02315); class: H Shares; reason: 1201 (L); transaction: 999,500(L) Source ↗
- HKEX-DI-undefined · 2026-09-17 · CMBI Private Equity Series SPC disclosed an HKEX interest in Biocytogen Pharmaceuticals (Beijing) Co., Ltd.- B - H Shares (02315); class: H Shares; reason: 1201 (L); transaction: 999,500(L) Source ↗
- HKEX-DI-undefined · 2026-09-17 · CMB International Private Investment Limited disclosed an HKEX interest in Biocytogen Pharmaceuticals (Beijing) Co., Ltd.- B - H Shares (02315); class: H Shares; reason: 1201 (L); transaction: 999,500(L) Source ↗
- HKEX-DI-undefined · 2026-09-17 · CMB International Investment Management Limited disclosed an HKEX interest in Biocytogen Pharmaceuticals (Beijing) Co., Ltd.- B - H Shares (02315); class: H Shares; reason: 1201 (L); transaction: 999,500(L) Source ↗
- HKEX-DI-undefined · 2026-09-17 · Astral Eminent Limited disclosed an HKEX interest in Biocytogen Pharmaceuticals (Beijing) Co., Ltd.- B - H Shares (02315); class: H Shares; reason: 1201 (L); transaction: 999,500(L) Source ↗
Latest filings
- HKEX-DI-undefined · 2026-09-24 · 招銀國際金融有限公司 Official filing ↗
- HKEX-DI-undefined · 2026-09-24 · 招銀國際金融控股有限公司 Official filing ↗
- HKEX-DI-undefined · 2026-09-24 · 招商銀行股份有限公司 Official filing ↗
- HKEX-DI-undefined · 2026-09-24 · CMBI Private Equity Series SPC Official filing ↗
- HKEX-DI-undefined · 2026-09-24 · CMB International Private Investment Limited Official filing ↗
- HKEX-DI-undefined · 2026-09-24 · CMB International Investment Management Limited Official filing ↗
- HKEX-DI-undefined · 2026-09-24 · Astral Eminent Limited Official filing ↗
- HKEX-DI-undefined · 2026-09-23 · 招銀國際金融有限公司 Official filing ↗
- HKEX-DI-undefined · 2026-09-23 · 招銀國際金融控股有限公司 Official filing ↗
- HKEX-DI-undefined · 2026-09-23 · 招商銀行股份有限公司 Official filing ↗
- HKEX-DI-undefined · 2026-09-23 · CMBI Private Equity Series SPC Official filing ↗
- HKEX-DI-undefined · 2026-09-23 · CMB International Private Investment Limited Official filing ↗
- HKEX-DI-undefined · 2026-09-23 · CMB International Investment Management Limited Official filing ↗
- HKEX-DI-undefined · 2026-09-23 · Astral Eminent Limited Official filing ↗